Simplex Trading
INDV icon

Simplex Trading’s Indivior Pharmaceuticals INDV Stock Holding History

Simplex Trading’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
28,500
+24,000
+533% +$871K ﹤0.01% 2615
2026
Q1 		$137K Sell
4,500
-11,300
-72% -$373K ﹤0.01% 4728
2025
Q4 		$567K Sell
15,800
-147,500
-90% -$4.5M ﹤0.01% 3177
2025
Q3 		$3.94M Buy
163,300
+135,200
+481% +$2.83M ﹤0.01% 1688
2025
Q2 		$414K Buy
28,100
+21,700
+339% +$253K ﹤0.01% 3713
2025
Q1 		$60K Buy
6,400
+6,000
+1,500% +$63.1K ﹤0.01% 5591
2024
Q4 		$4K Buy
+400
New +$4.12K ﹤0.01% 7746
2024
Q3 		– Sell
-67,200
Closed -$1.08M – 8979
2024
Q2 		$1.08M Buy
+67,200
New +$1.21M ﹤0.01% 2836

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's INDV Position: Q2 2026 in Review

Simplex Trading sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 10,533 shares — an estimated $382K sold.

Simplex Trading first reported a position in INDV in Q4 2024 and held it in 3 quarters. The position peaked at $362K in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Simplex Trading reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 10,533 Indivior Pharmaceuticals shares in Q2 2026, an estimated $382K.
  • Simplex Trading first reported a position in Indivior Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Simplex Trading's Indivior Pharmaceuticals position peaked at $362K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.